Chai-Adisaksopha, C.; Noone, D.; Curtis, R.; Frick, N.; Nichol, M. B.; Germini, F.; O'Mahony, B.; Page, D.; Stonebraker, J. S.; Skinner, M. W.; Iorio, A., Non-severe haemophilia: Is it benign? – Insights from the PROBE study, «HAEMOPHILIA», 2021, 27, pp. 17 - 24 [Scientific article]
Kavanagh, P. L.; Frater, F.; Navarro, T.; Lavita, P.; Parrish, R.; Iorio, A., Optimizing a literature surveillance strategy to retrieve sound overall prognosis and risk assessment model papers, «JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION», 2021, 28, pp. 766 - 771 [Scientific article]
Aquino, C. C.; Borg Debono, V.; Germini, F.; Pete, D.; Kempton, C. L.; Young, G.; Sidonio, R.; Croteau, S. E.; Dunn, A. L.; Key, N. S.; Iorio, A., Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders, «HAEMOPHILIA», 2021, 27, pp. 211 - 220 [Scientific article]
Van Balen, E. C.; O'Mahony, B.; Cnossen, M. H.; Dolan, G.; Blanchette, V. S.; Fischer, K.; Gue, D.; O'Hara, J.; Iorio, A.; Jackson, S.; Konkle, B. A.; Nugent, D. J.; Coffin, D.; Skinner, M. W.; Smit, C.; Srivastava, A.; Van Eenennaam, F.; Van Der Bom, J. G.; Gouw, S. C., Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes set, «RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS», 2021, 5, Article number: e12488 , pp. 1 - 10 [Scientific article]
Yu, J. K.; Iorio, A.; Chelle, P.; Edginton, A. N., Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study, «HAEMOPHILIA», 2021, 27, pp. 358 - 365 [Scientific article]
Spinella, Philip C; El Kassar, Nahed; Cap, Andrew P; Kindzelski, Andrei L; Almond, Christopher S; Barkun, Alan; Gernsheimer, Terry B; Goldstein, Joshua N; Holcomb, John B; Iorio, Alfonso; Jensen, Dennis M; Key, Nigel S; Levy, Jerrold H; Mayer, Stephan A; Moore, Ernest E; Stanworth, Simon J; Lewis, Roger J; Steiner, Marie E, Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference, «THE JOURNAL OF TRAUMA AND ACUTE CARE SURGERY», 2021, 91, pp. 19 - 25 [Scientific article]
Versloot, O.; Iserman, E.; Chelle, P.; Germini, F.; Edginton, A. N.; Schutgens, R. E. G.; Iorio, A.; Fischer, K., Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2021, 19, pp. 1896 - 1906 [Scientific article]
Sun, H.; Yang, M.; Poon, M. -C.; Lee, A.; Robinson, K. S.; Sholzberg, M.; Wu, J.; Iorio, A.; Blanchette, V.; Carcao, M.; Klaassen, R. J.; Jackson, S., The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B, «RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS», 2021, 5, Article number: e12601 , pp. 1 - 10 [Scientific article]
Pottie, K.; Magwood, O.; Rahman, P.; Concannon, T.; Alonso-Coello, P.; Jaramillo Garcia, A.; Santesso, N.; Thombs, B.; Welch, V.; Wells, G. A.; Saad, A.; Archibald, D.; Grad, R.; Moore, A.; Ximena Rojas, M.; Iorio, A.; Pinto, N.; Doull, M.; Morton, R.; Akl, E. A.; Schunemann, H. J.; Tugwell, P., Validating the “feasibility, acceptability, cost, and equity” instrument using stakeholder perceptions of feasibility, acceptability, cost, and equity in guideline implementation, «JOURNAL OF CLINICAL EPIDEMIOLOGY», 2021, 131, pp. 133 - 140 [Scientific article]
Yu, J. K.; Iorio, A.; Edginton, A. N., A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients, «THROMBOSIS RESEARCH», 2020, 196, pp. 550 - 558 [Scientific article]
Hay, C. R. M.; Shima, M.; Makris, M.; Jimenez-Yuste, V.; Oldenburg, J.; Fischer, K.; Iorio, A.; Skinner, M. W.; Santagostino, E.; Von Mackensen, S.; Kessler, C. M., Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company, «HAEMOPHILIA», 2020, 26, pp. 966 - 974 [Scientific article]
McEneny-King, A.; Yeung, C. H. T.; Edginton, A. N.; Iorio, A.; Croteau, S. E., Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS-Hemo): Patterns of blood sampling and patient characteristics among clinician users, «HAEMOPHILIA», 2020, 26, pp. 56 - 63 [Scientific article]
Brian Haynes, R.; Del Fiol, G.; Michelson, M.; Iorio, A., Context and approach in reporting evaluations of electronic health record-based implementation projects, «ANNALS OF INTERNAL MEDICINE», 2020, 172, pp. 573 - 578 [Scientific article]
Konkle, B.; Pierce, G.; Coffin, D.; Naccache, M.; Clark, R. C.; George, L.; Iorio, A.; O'Mahony, B.; Pipe, S.; Skinner, M.; Watson, C.; Peyvandi, F.; Mahlangu, J., Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2020, 18, pp. 3074 - 3077 [Scientific article]
Alexander, P. E.; Debono, V. B.; Mammen, M. J.; Iorio, A.; Aryal, K.; Deng, D.; Brocard, E.; Alhazzani, W., COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine, «JOURNAL OF CLINICAL EPIDEMIOLOGY», 2020, 123, pp. 120 - 126 [Scientific article]
